Trial Profile
Clinical Trials Insight: 700044160
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2010
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors INSYS Therapeutics, Inc
- 27 Aug 2010 Enrollment in this trial is expected to begin shortly, as reported in a NeoPharm media release.